Insider Transactions in Q2 2022 at Acutus Medical, Inc. (AFIB)
Insider Transaction List (Q2 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 16
2022
|
James E Flynn Director |
BUY
Grant, award, or other acquisition
|
Indirect |
8,400
+40.34%
|
-
|
|
Jun 16
2022
|
David P Bonita Director |
BUY
Grant, award, or other acquisition
|
Direct |
8,400
+40.34%
|
-
|
|
Jun 16
2022
|
Andrew El Bardissi Director |
BUY
Grant, award, or other acquisition
|
Direct |
8,400
+40.34%
|
-
|
|
Jun 16
2022
|
Daniella Cramp Director |
BUY
Grant, award, or other acquisition
|
Direct |
8,400
+41.95%
|
-
|
|
Jun 16
2022
|
John F Sheridan Director |
BUY
Grant, award, or other acquisition
|
Direct |
8,400
+34.5%
|
-
|
|
Jun 16
2022
|
Niamh Louise Pellegrini Director |
BUY
Grant, award, or other acquisition
|
Direct |
8,400
+40.05%
|
-
|
|
Jun 16
2022
|
R Scott Huennekens Director |
BUY
Grant, award, or other acquisition
|
Direct |
8,400
+50.0%
|
-
|
|
Jun 16
2022
|
James F. Hinrichs Director |
BUY
Grant, award, or other acquisition
|
Direct |
8,400
+12.05%
|
-
|
|
Jun 16
2022
|
Shaden Marzouk Director |
BUY
Grant, award, or other acquisition
|
Direct |
8,400
+40.34%
|
-
|
|
Jun 03
2022
|
R Scott Huennekens Director |
SELL
Open market or private sale
|
Indirect |
60,000
-10.57%
|
$0
$0.58 P/Share
|
|
Jun 01
2022
|
David Roman President & CEO |
BUY
Grant, award, or other acquisition
|
Direct |
100,000
+35.29%
|
-
|
|
Apr 01
2022
|
David Roman President & CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
3,248
-3.75%
|
$3,248
$1.3 P/Share
|
|
Apr 01
2022
|
Steven Mc Quillan SVP, Clinical Affairs & QA |
SELL
Payment of exercise price or tax liability
|
Direct |
733
-1.57%
|
$733
$1.3 P/Share
|
|
Apr 01
2022
|
Vincent J Burgess Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
3,896
-5.96%
|
$3,896
$1.3 P/Share
|